Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting Academic Article uri icon

Overview

MeSH Major

  • Coronary Artery Bypass
  • Coronary Disease
  • Peptides
  • Platelet Aggregation Inhibitors

abstract

  • Eptifibatide administration in patients undergoing in-hospital CABG with a recent episode of a non-ST-segment elevation acute coronary syndrome results in a significant reduction in death or MI that is evident at 7 days and persists through the 6-month follow-up without a significant increase in perioperative bleeding rates.

publication date

  • December 12, 2000

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 11113045

Additional Document Info

start page

  • 2952

end page

  • 8

volume

  • 102

number

  • 24